Brainstorm Cell Therapeutics, Inc. (BCLI)

0.75 +0.03 (+4.02%) USD  |  OTCM  |  May 29, 16:00
More

Brainstorm Cell Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade